Cellular lineage origins of spasmolytic polypeptide-expressing metaplasia (SPEM): persistent and intensifying debates

Xiaofeng Li1, Yu Li2, Lili Wu3

  • 1First Clinical Medical College, Heilongjiang University of Chinese Medicine, Harbin, China.

Frontiers in Oncology
|November 6, 2025
PubMed

Insights

Spasmolytic Polypeptide-Expressing Metaplasia (SPEM) arises from gastric injury. Current research debates whether SPEM originates from passive chief cell changes or active chief cell loss and stem cell involvement.

Area of Science:

  • Gastroenterology
  • Cell Biology
  • Oncology

Background:

  • Spasmolytic Polypeptide-Expressing Metaplasia (SPEM) is a gastric metaplasia linked to injury, Helicobacter pylori, and bile reflux.
  • SPEM is a risk factor for gastric cancer development if damaging stimuli persist.
  • The cellular origins of SPEM are debated, with traditional views challenged by recent findings.

Purpose of the Study:

  • To review the physicochemical drivers of SPEM.
  • To critically evaluate the proposed cellular origins of SPEM.
  • To synthesize current research on SPEM development.

Main Methods:

  • Literature review and synthesis of existing research.
  • Critical evaluation of evidence for different cellular origins.
  • Analysis of physicochemical factors contributing to SPEM.

Main Results:

  • SPEM can arise from passive chief cell transdifferentiation, active chief cell depletion, or isthmus stem cell involvement.
  • Evidence suggests multiple pathways contribute to SPEM development, indicating heterogeneity.
  • Further research with specific cell ablation techniques is needed to clarify SPEM origins.

Conclusions:

  • The cellular origin of SPEM is complex and likely involves multiple mechanisms.
  • Understanding SPEM's heterogeneous origins is crucial for assessing gastric cancer risk.
  • Classifying current research is essential for guiding future investigations into SPEM.